Which Antiplatelet Therapy for Which Patient? Dr. Thomas Cuisset

More articles by this author

Chronic Cerebrospinal Venous Insufficiency (CCSVI): Diagnosis and Management Marjeta Zorc, MD

Chronic Cerebrospinal Venous Insufficiency (CCSVI): Diagnosis and Management Marjeta Zorc, MD

Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD

Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD

Recent Advances in the Evaluation of the TAVI Candidate Alfonso Medina, MD

Recent Advances in the Evaluation of the TAVI Candidate Alfonso Medina, MD

Bleeding Risk Estimation and the New (BARC) Definition of Bleeding Events Dr. Franz Weidinger

Bleeding Risk Estimation and the New (BARC) Definition of Bleeding Events Dr. Franz Weidinger

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...